You are here
VINDICO NANOBIOTECHNOLOGY, INC.
http://vindicopharma.com
UEI: N/A
# of Employees: 3
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
A transfollicular nanovaccine against leishmaniasis
Amount: $600,000.00DESCRIPTION (provided by applicant): The World Health Organization estimates that over 350 million people are at risk of developing leishmaniasis and infection prevalence is 14 million people in the w ...
SBIRPhase I2011Department of Health and Human Services National Institutes of Health -
Modulation of In Vivo Tumor Oxygenation via Polymersome-encapsulated Myoglobin
Amount: $299,888.00DESCRIPTION (provided by applicant): Over 250,000 new cases of head and neck cancers (HNCs) and non-small cell lung cancers (NSCLCs) are diagnosed every year in the United States. At the time of diagn ...
SBIRPhase I2011Department of Health and Human Services National Institutes of Health -
Fully Biodegradable Polymersome-encapsulated Hemoglobin as a Novel Nanoparticle-b
Amount: $199,683.00DESCRIPTION (provided by applicant): Vindico NanoBioTechnology Inc. (Vindico) is developing a hemoglobin-based cellular oxygen therapeutic (blood substitute), NanoHeme, based on its proprietary na ...
SBIRPhase I2010Department of Health and Human Services National Institutes of Health